ArticleCancers2022

Novel Dicarboximide BK124.1 Breaks Multidrug Resistance and Shows Anticancer Efficacy in Chronic Myeloid Leukemia Preclinical Models and Patients' CD34

Iga Stukan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.